Cancer risks and lacidipine--an explanation
Lindholm, L.H.
Lakartidningen 93(43): 3770
1996
ISSN/ISBN: 0023-7205 PMID: 8965546 Document Number: 461970
Document emailed within 1 workday
Related Documents
Leonetti, G. 1991: Comparative study of lacidipine and nifedipine SR in the treatment of hypertension: an Italian multicenter study. The Northern Italian Study Group of Lacidipine in Hypertension Journal of Cardiovascular Pharmacology 17(Suppl 4): S31-S34Timmermans, D.R.M.; Oudhoff, J. 2012: Indicating risks in the Dutch Cancer Society Cancer Risk Test: indicating population risks improves risk perception Nederlands tijdschrift voor geneeskunde 156(21): A4961
Kennedy, J.W. 1973: Cancer immunotherapy. a new explanation for some old observations Arizona Medicine 30(5): 347-348
Gilbert, E.S. 1994: Smoking as an explanation for the negative relationship between exposure to radon and certain types of cancer Health Physics 67(2): 197-198
Suissa, S.; Pollak, M.; Spitzer, W.O.; Margolese, R. 1989: Body size and breast cancer prognosis: a statistical explanation of the discrepancies Cancer Research 49(11): 3113-3116
Giacometti, A.; Micheli, D.; Gaviraghi, G.; Trist, D.G. 1994: Quantification of the calcium antagonism of lacidipine by kinetic analysis Journal of Pharmacology and Experimental Therapeutics 269(1): 424-429
Trazzi, S.; Santucciu, C.; Mancia, G. 1993: Radial artery compliance in essential hypertension: effects of antihypertensive therapy with lacidipine Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 11(6): S17-S20
Peto, R. 1983: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today NATO advanced study institutes series Series A Life sciences 60: 587-593
Martin, J.; Kauer, S.D.; Sanci, L. 2016: Road safety risks in young people attending general practice: A cross-sectional study of road risks and associated health risks Australian Family Physician 45(9): 666-672
Chow, W.H.; Malker, H.S.; Hsing, A.W.; McLaughlin, J.K.; Weiner, J.A.; Stone, B.J.; Ericsson, J.L.; Blot, W.J. 1994: Occupational risks for colon cancer in Sweden Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 36(6): 647-651
Malker, H.S.; McLaughlin, J.K.; Silverman, D.T.; Ericsson, J.L.; Stone, B.J.; Weiner, J.A.; Malker, B.K.; Blot, W.J. 1987: Occupational risks for bladder cancer among men in Sweden Cancer Research 47(24 Pt 1): 6763-6766
Laerum, O.D.; Haugen, A.; Mørk, S.J.; Norseth, T. 1983: Cancer risks connected to oil processing and oil products Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 103(34-36): 2300-2305
Alouini, S.; Venslauskaite, G.; Lubarskiene, Z. 2015: Contraception with levonorgestrel system and risks of breast cancer American Journal of Obstetrics and Gynecology 212(2): 255
Rogan, E. 2007: Xenoestrogens, biotransformation, and differential risks for breast cancer Alternative Therapies in Health and Medicine 13(2): S112-S121
Henry, S.H.; Bosch, F.Xavier.; Bowers, J.C. 2002: Aflatoxin, hepatitis and worldwide liver cancer risks Advances in Experimental Medicine and Biology 504: 229-233
Grossarth-Maticek, R.; Frentzel-Beyme, R.; Becker, N. 1984: Cancer risks associated with life events and conflict solution Cancer Detection and Prevention 7(3): 201-209
Basso-Ricci, S.; Sverzellati, E.; Coopmans de Yoldi, G.F. 1985: How much can the risks of sequelae from radiotherapy for breast cancer be reduced? Panminerva Medica 27(4): 195-199
Hayes, R.B.; Pottern, L.M.; Strickler, H.; Rabkin, C.; Pope, V.; Swanson, G.M.; Greenberg, R.S.; Schoenberg, J.B.; Liff, J.; Schwartz, A.G.; Hoover, R.N.; Fraumeni, J.F. 2000: Sexual behaviour, STDs and risks for prostate cancer British Journal of Cancer 82(3): 718-725
Freak, J. 2003: Nurses' role in public education on the risks of skin cancer Nursing Times 99(25): 30-32
Khoo, S.K. 1985: The contraceptive pill and cancer risks what is the evidence after 20 years experience? Clinical Reproduction and Fertility 3(2): 160-162